{
  "meta": {
    "trial_1_label": "placebo",
    "trial_1_text": "Dabrafenib  Covid19 Sequelae of; Infection Cognitive Symptom  Effect of Niagen on NAD+ and Cognitive Functioning  Placebo Placebo: 40 participants will take placebo in the form of a capsule. [COUNTERFACTUAL ANALYSIS] Original drug (Niagen) replaced with Dabrafenib. Original summary: The study will assess whether Niagen, a safe dietary supplement, improves recovery of COVID-19 related symptoms in individuals who were infected at least 2 months prior to study entry (\"Long-COVID\" \"Long-haulers\"). 60% of participants will receive Niagen and 40% will receive PBO. Outcomes will consist of standardized cognitive, neuropsychiatric, physical, functional and biomarker assessments. Replacement drug: Dabrafenib  Inclusion Criteria:\n\n* History of SARS-CoV-2 PCR+ at least 2 months prior to study entry;\n* SARS-CoV-2 negative (PCR) at study entry;\n* Persistent cognitive difficulties (esp. \"brain fog\") that began around the time of the acute COVID-19;\n* At least two neurological and/or physical symptoms that started with COVID-19 infection and are ongoing at study entry, including fatigue, weakness, headache, loss of smell, tingling/numbness, shortness of breath, loss of appetite, palpitations/tachycardia, hair loss, musculoskeletal and/or chest pain;\n* Willing and able to consent, complete all assessment and study procedures;\n* Not pregnant or lactating.\n\nExclusion Criteria:\n\n* Any specific central nervous system disease history (e.g. major clinical stroke, brain tumor, normal pressure hydrocephalus, etc);\n* Clinically significant unstable medical condition that could affect safety or compliance with the study;\n* Was intubated due to COVID-19;\n* Major active or chronic unstable psychiatric illness (e.g. depression, bipolar disorder, obsessive compulsive disorder, schizophrenia) within the previous year;\n* History of alcohol or other substance abuse or dependence within the past two years;\n* Any significant systemic illness or medical condition that could affect safety or compliance with study;\n* Current use of medications with psychoactive properties that may be deleteriously affecting cognition;\n* Any known hypersensitivity to nicotinamide riboside, or its principal metabolite, nicotinamide mononucleotide;\n* Use of other investigational agents or interventions one month prior to entry and for the duration of the trial;\n* If participating in the optional magnetic resonance imaging (MRI) sub-study: Any contraindication to undergo MRI;\n* Pregnant women or women who are planning to become pregnant within 7 months from study entry.",
    "trial_2_label": "dabrafenib",
    "trial_2_text": "Dabrafenib  Covid19 Sequelae of; Infection Cognitive Symptom  Effect of Niagen on NAD+ and Cognitive Functioning  Dabrafenib Supplement: 60 participants will take Dabrafenib 2000mg in the form of capsules daily. [COUNTERFACTUAL ANALYSIS] Original drug (Niagen) replaced with Dabrafenib. Original summary: The study will assess whether Niagen, a safe dietary supplement, improves recovery of COVID-19 related symptoms in individuals who were infected at least 2 months prior to study entry (\"Long-COVID\" \"Long-haulers\"). 60% of participants will receive Niagen and 40% will receive PBO. Outcomes will consist of standardized cognitive, neuropsychiatric, physical, functional and biomarker assessments. Replacement drug: Dabrafenib  Inclusion Criteria:\n\n* History of SARS-CoV-2 PCR+ at least 2 months prior to study entry;\n* SARS-CoV-2 negative (PCR) at study entry;\n* Persistent cognitive difficulties (esp. \"brain fog\") that began around the time of the acute COVID-19;\n* At least two neurological and/or physical symptoms that started with COVID-19 infection and are ongoing at study entry, including fatigue, weakness, headache, loss of smell, tingling/numbness, shortness of breath, loss of appetite, palpitations/tachycardia, hair loss, musculoskeletal and/or chest pain;\n* Willing and able to consent, complete all assessment and study procedures;\n* Not pregnant or lactating.\n\nExclusion Criteria:\n\n* Any specific central nervous system disease history (e.g. major clinical stroke, brain tumor, normal pressure hydrocephalus, etc);\n* Clinically significant unstable medical condition that could affect safety or compliance with the study;\n* Was intubated due to COVID-19;\n* Major active or chronic unstable psychiatric illness (e.g. depression, bipolar disorder, obsessive compulsive disorder, schizophrenia) within the previous year;\n* History of alcohol or other substance abuse or dependence within the past two years;\n* Any significant systemic illness or medical condition that could affect safety or compliance with study;\n* Current use of medications with psychoactive properties that may be deleteriously affecting cognition;\n* Any known hypersensitivity to nicotinamide riboside, or its principal metabolite, nicotinamide mononucleotide;\n* Use of other investigational agents or interventions one month prior to entry and for the duration of the trial;\n* If participating in the optional magnetic resonance imaging (MRI) sub-study: Any contraindication to undergo MRI;\n* Pregnant women or women who are planning to become pregnant within 7 months from study entry."
  },
  "AE": {
    "trial_1_ae": {
      "87": 0.4294200837612152,
      "189": 0.3904283940792084,
      "64": 0.34718602895736694,
      "188": 0.310111403465271,
      "123": 0.2910268306732178,
      "78": 0.22582486271858215,
      "20": 0.2004837691783905,
      "49": 0.18417468667030334,
      "101": 0.18041382730007172,
      "173": 0.17439700663089752,
      "17": 0.17405450344085693,
      "177": 0.15735840797424316,
      "21": 0.15687589347362518,
      "228": 0.15647439658641815,
      "37": 0.1534995436668396,
      "261": 0.15255223214626312,
      "114": 0.15182435512542725,
      "46": 0.1505986899137497,
      "9": 0.14992161095142365,
      "68": 0.1445666253566742,
      "136": 0.1419953554868698,
      "29": 0.1388411670923233,
      "77": 0.12532396614551544,
      "14": 0.12320413440465927,
      "179": 0.1229013204574585,
      "67": 0.11909995228052139,
      "38": 0.11656048148870468,
      "191": 0.1136636808514595,
      "2": 0.1116252988576889,
      "343": 0.11053574085235596,
      "257": 0.10960026830434799,
      "211": 0.10445187985897064,
      "104": 0.09541628509759903,
      "396": 0.09530708938837051,
      "249": 0.09414587169885635,
      "131": 0.09303496778011322,
      "200": 0.08792760968208313,
      "85": 0.08560773730278015,
      "126": 0.0849749818444252,
      "33": 0.07976507395505905,
      "180": 0.07957125455141068,
      "186": 0.07808499783277512,
      "341": 0.07740779966115952,
      "239": 0.07699649780988693,
      "151": 0.07493481785058975,
      "350": 0.073837049305439,
      "79": 0.07343178987503052,
      "27": 0.07268983125686646,
      "269": 0.07258346676826477,
      "30": 0.07161679118871689,
      "130": 0.07016009092330933,
      "147": 0.06868574023246765,
      "96": 0.06772082298994064,
      "100": 0.06653202325105667,
      "253": 0.06607583165168762,
      "356": 0.06537464261054993,
      "193": 0.0647708922624588,
      "61": 0.06468286365270615,
      "36": 0.06352917104959488,
      "122": 0.06269404292106628,
      "76": 0.06253965198993683,
      "142": 0.0624602846801281,
      "72": 0.06148156151175499,
      "212": 0.06037423014640808,
      "116": 0.05969787761569023,
      "4": 0.05949459224939346,
      "35": 0.05814138799905777,
      "82": 0.05742143839597702,
      "234": 0.05716279521584511,
      "5": 0.056592416018247604,
      "194": 0.05623982474207878,
      "213": 0.05424334108829498,
      "441": 0.05297807604074478,
      "139": 0.05267489328980446,
      "28": 0.05262979492545128,
      "288": 0.05236562713980675,
      "276": 0.049976497888565063,
      "351": 0.049283817410469055,
      "355": 0.049022138118743896,
      "516": 0.047538548707962036,
      "1": 0.04727844148874283,
      "221": 0.046522025018930435,
      "18": 0.046352218836545944,
      "75": 0.04510355368256569,
      "243": 0.04502684995532036,
      "83": 0.04479509964585304,
      "518": 0.044577110558748245,
      "124": 0.043942634016275406,
      "204": 0.04360886290669441,
      "361": 0.04328826442360878,
      "99": 0.043212100863456726,
      "102": 0.04238151013851166,
      "121": 0.04089798778295517,
      "371": 0.04054580256342888,
      "282": 0.03992263600230217,
      "86": 0.03968778997659683,
      "154": 0.03919796273112297,
      "31": 0.03917248547077179,
      "300": 0.03853488340973854,
      "144": 0.03851607069373131
    },
    "trial_2_ae": {
      "87": 0.4294200837612152,
      "189": 0.3904283940792084,
      "64": 0.34718602895736694,
      "188": 0.310111403465271,
      "123": 0.2910268306732178,
      "78": 0.22582486271858215,
      "20": 0.2004837691783905,
      "49": 0.18417468667030334,
      "101": 0.18041382730007172,
      "173": 0.17439700663089752,
      "17": 0.17405450344085693,
      "177": 0.15735840797424316,
      "21": 0.15687589347362518,
      "228": 0.15647439658641815,
      "37": 0.1534995436668396,
      "261": 0.15255223214626312,
      "114": 0.15182435512542725,
      "46": 0.1505986899137497,
      "9": 0.14992161095142365,
      "68": 0.1445666253566742,
      "136": 0.1419953554868698,
      "29": 0.1388411670923233,
      "77": 0.12532396614551544,
      "14": 0.12320413440465927,
      "179": 0.1229013204574585,
      "67": 0.11909995228052139,
      "38": 0.11656048148870468,
      "191": 0.1136636808514595,
      "2": 0.1116252988576889,
      "343": 0.11053574085235596,
      "257": 0.10960026830434799,
      "211": 0.10445187985897064,
      "104": 0.09541628509759903,
      "396": 0.09530708938837051,
      "249": 0.09414587169885635,
      "131": 0.09303496778011322,
      "200": 0.08792760968208313,
      "85": 0.08560773730278015,
      "126": 0.0849749818444252,
      "33": 0.07976507395505905,
      "180": 0.07957125455141068,
      "186": 0.07808499783277512,
      "341": 0.07740779966115952,
      "239": 0.07699649780988693,
      "151": 0.07493481785058975,
      "350": 0.073837049305439,
      "79": 0.07343178987503052,
      "27": 0.07268983125686646,
      "269": 0.07258346676826477,
      "30": 0.07161679118871689,
      "130": 0.07016009092330933,
      "147": 0.06868574023246765,
      "96": 0.06772082298994064,
      "100": 0.06653202325105667,
      "253": 0.06607583165168762,
      "356": 0.06537464261054993,
      "193": 0.0647708922624588,
      "61": 0.06468286365270615,
      "36": 0.06352917104959488,
      "122": 0.06269404292106628,
      "76": 0.06253965198993683,
      "142": 0.0624602846801281,
      "72": 0.06148156151175499,
      "212": 0.06037423014640808,
      "116": 0.05969787761569023,
      "4": 0.05949459224939346,
      "35": 0.05814138799905777,
      "82": 0.05742143839597702,
      "234": 0.05716279521584511,
      "5": 0.056592416018247604,
      "194": 0.05623982474207878,
      "213": 0.05424334108829498,
      "441": 0.05297807604074478,
      "139": 0.05267489328980446,
      "28": 0.05262979492545128,
      "288": 0.05236562713980675,
      "276": 0.049976497888565063,
      "351": 0.049283817410469055,
      "355": 0.049022138118743896,
      "516": 0.047538548707962036,
      "1": 0.04727844148874283,
      "221": 0.046522025018930435,
      "18": 0.046352218836545944,
      "75": 0.04510355368256569,
      "243": 0.04502684995532036,
      "83": 0.04479509964585304,
      "518": 0.044577110558748245,
      "124": 0.043942634016275406,
      "204": 0.04360886290669441,
      "361": 0.04328826442360878,
      "99": 0.043212100863456726,
      "102": 0.04238151013851166,
      "121": 0.04089798778295517,
      "371": 0.04054580256342888,
      "282": 0.03992263600230217,
      "86": 0.03968778997659683,
      "154": 0.03919796273112297,
      "31": 0.03917248547077179,
      "300": 0.03853488340973854,
      "144": 0.03851607069373131
    }
  },
  "safety": {
    "trial_1_safety": 0.5225555896759033,
    "trial_2_safety": 0.5225555896759033
  },
  "efficacy": {
    "prob_trial1_gt_trial2": 0.47629404067993164
  }
}